RVPH icon

Reviva Pharmaceuticals
RVPH

Overview Fund Activity

13 hedge funds and large institutions have $19M invested in Reviva Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OAM
Oxford Asset Management
United Kingdom
+$3.65M
2
MSU
Mizuho Securities USA
New York
+$3.08M
3
PC
Periscope Capital
Ontario, Canada
+$2.38M
4
CFIC
City Financial Investment Company
United Kingdom
+$2.38M
5
WAM
Weiss Asset Management
Massachusetts
+$2.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
OAM
1
Oxford Asset Management
United Kingdom
$3.65M +$3.65M +370,300 New
MSU
2
Mizuho Securities USA
New York
$3.08M +$3.08M +313,492 New
PC
3
Periscope Capital
Ontario, Canada
$2.38M +$2.38M +241,700 New
CFIC
4
City Financial Investment Company
United Kingdom
$2.38M +$2.38M +241,500 New
WAM
5
Weiss Asset Management
Massachusetts
$2.02M +$2.02M +204,998 New
Goldman Sachs
6
Goldman Sachs
New York
$1.47M +$1.47M +150,000 New
PAM
7
Panagora Asset Management
Massachusetts
$1.15M +$1.15M +116,337 New
HIM
8
HGC Investment Management
Ontario, Canada
$656K +$656K +66,500 New
BI
9
Bulldog Investors
New Jersey
$533K +$533K +54,305 New
BCM
10
Basso Capital Management
Connecticut
$495K +$495K +50,300 New
PAMP
11
Polar Asset Management Partners
Ontario, Canada
$492K +$492K +50,000 New
GCL
12
Glazer Capital LLC
New York
$491K +$491K +50,000 New
CI
13
Cowen Inc
New York
$246K +$246K +25,100 New